Mycoses

Article	Citations
	198
Issue Information	156
Immunohistochemical analysis of chronic and recurrent dermatophytosis	128
High attenuation mucus in bronchi with allergic bronchopulmonary mycosis	103
	81
Intra‐ and inter‐laboratory comparison of mDixon and FastFung broths for Malassezia antifungal susceptibility testing	80
Development of single‐tube real‐time PCR assay for the rapid detection of Aspergillus and Fusarium—The two most common causative agents in fungal keratitis	70
Issue Information	52
Issue Information	45
Vaginal microbiota in pregnant women with inflammatory rheumatic and inflammatory bowel disease: A matched case‐control study	44
Issue Information	43
Comparison of four diagnostic criteria for invasive pulmonary aspergillosis—A diagnostic accuracy study in critically ill patients	42
Physicians' knowledge of invasive fungal disease in China	40
	38
Seasonality of sporotrichosis in Brazil: A modelled analysis of the epidemic in São Paulo, 2011–2020	37
	37
Author Index	36
In vitro activities of 8 antifungal drugs against 126 clinical and environmental Exophiala isolates	35
Issue Information	34
Multi‐state evaluation of Candida infections in burn patients	33
A retrospective Italian analysis on the characteristics of invasive fungal infections in the intensive care unit setting: CHARTER‐IFI study	32
Issue Information	29
Molecular Epidemiology and Antifungal Susceptibility Profile of Candidozyma Isolates From Argentina	29
Clinical characteristics and risk factors for late‐onset pneumocystis jirovecii pneumonia in kidney transplantation recipients	29
Review Article White Piedra: Review of 131 cases	27

Therapeutic drug monitoring of posaconazole delayed release tablet while managing COVID‐19–associated mucormycosis in a real‐life setting	25
Evaluation of the CHROMagar Candida Plus medium for presumptive identification of yeasts and MALDI‐TOF MS identification	25
Risk factors for pulmonary mucormycosis in subjects with diabetes mellitus—A case‐control study	25
Systemic antifungal therapy with isavuconazonium sulfate or other agents in adults with invasive mucormycosis or invasive aspergillosis (non‐fumigatus): A multicentre, non‐interventional regist	25
Endemic mycoses: Expansion of traditional geographic ranges and pitfalls in management	25
A longitudinal study on fluconazole resistance in Candida albicans vaginal isolates	25
Clinical characteristics and outcomes of invasive and non‐invasive fusariosis in South Korea	25
Natural history and prognostic factors of candidemia in kidney transplant recipients: A retrospective, multinational study	25
Mucocutaneous mycoses in people living with human immunodeficiency virus in Indonesia	24
Cover image	24
	23
Issue Information	23
	23
NLRP3 regulates CIITA/MHC II axis and interferon‐γ‐inducible chemokines in Malassezia globosa‐infected keratinocytes	22
A contemporary investigation of burden and natural history of aspergillosis in people living with HIV/AIDS	22
COVID‐19‐associated subacute invasive pulmonary aspergillosis	22
Exome Sequencing of a Blastomycosis Case–Control Cohort From Manitoba and Northwestern Ontario, Canada	21
In vitro activity of 23 antifungal drugs against 54 clinical and environmental Aspergillus oryzae isolates	21
Novel cases of cutaneous phaeohyphomycosis by Alternaria alstromeriae, Epicoccum tritici and Phialemonium obovatum from North India	21
Identification of primary metabolites in fungal species of Trichophyton mentagrophyte and Trichophyton rubrum by NMR spectroscopy	21
Secondary invasive fungal infection in hospitalised patients with COVID‐19 in the United States	20
	20
Comparative evaluation of host immune response and cytokine signature pertaining to Th1 and Th2 immune arms in serum and tissue among patients of acute localised vs. chronic disseminated de	20
Issue Information	19
	19
Issue Information	18
Intra‐Abdominal Candidiasis in Cancer Patients: A 10‐Year Experience in a Middle‐Income Country	17
Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta‐analysis	17
Sporothrix and Sporotrichosis: A South African Perspective on a Growing Global Health Threat	17
Epidemiological analysis of nail aspergillosis and non‐dermatophyte moulds. Criteria for the involvement of Aspergillus in 102 cases of onychomycosis at Montpellier University Hospital, France	16
Is there still a place for serum galactomannan in the diagnosis of invasive aspergillosis in children at high risk and under antifungal prophylaxis?	16
Low toxicity contributes to Sporothrix globosa invade the skin of patients in low‐epidemic areas of China	16
Systematic review of neuroparacoccidioidomycosis: The contribution of neuroimaging	16
Cover Image	16
Mucormycosis and COVID‐19: An epidemic within a pandemic in India	15
Current situation of endemic mycosis in the Americas and the Caribbean: Proceedings of the first international meeting on endemic mycoses of the Americas (IMEMA)	15
Clonal spread of fluconazole‐resistant C. parapsilosis in patients admitted to a referral hospital located in Burgos, Spain, during the COVID‐19 pandemic	15
Updated estimation of the burden of fungal disease in Vietnam	15
Identification of distinct immunophenotypes in chronic pulmonary aspergillosis using cluster analysis	15
The use of combined PCR, fluorescence in situ hybridisation and immunohistochemical staining to diagnose mucormycosis from formalin‐fixed paraffin‐embedded tissues	14
South Asian (Clade I) Candida auris meningitis in a paediatric patient in Iran with a review of the literature	14
	14
A thermal adaptation landscape related to virulence in Mucor irregularis transcriptional profiles	14
First detection of triazole‐resistant aspergillus fumigatus harbouring the TR34/L98H Cyp51A mutation in Burkina Faso	14
Genetic differences between Japan and other countries in cyp51A polymorphisms of Aspergillus fumigatus	14
Usefulness of 18F‐FDG PET‐CT for the management of invasive fungal infections: A retrospective cohort from a tertiary university hospital	14
Reimbursement of innovative pharmaceuticals in English and Spanish hospitals—The example of isavuconazole	14
Coccidioidomycosis in Oklahoma: A retrospective case series	14
Retrospective Epidemiology of Dermatomycosis in Kinshasa, Democratic Republic of Congo, From 2000 to 2023	13
Diverse Colonisation and Disease Associations of the Human Commensal Malassezia: Our Body's Secret Tenant	13

Candida albicans skin infection in diabetic patients: An updated review of pathogenesis and management	13
Cryptococcosis in the Democratic Republic of Congo from 1953 to 2021: A systematic review and meta‐analysis	13
Adhesive and biofilm‐forming Candida glabrata Lebanese hospital isolates harbour mutations in subtelomeric silencers and adhesins	13
Therapeutic efficacy of topically used luliconazole vs. terbinafine 1% creams	13
Microbiological culture combined with PCR for the diagnosis of onychomycosis: Descriptive analysis of 121 patients	12
COVID‐19‐associated aspergillosis in a Brazilian referral centre: Diagnosis, risk factors and outcomes	12
Global prevalence of onychomycosis in general and special populations: An updated perspective	12
State of Medical Mycology at German Academic Medical Centres: A Survey of the German‐Speaking Mycological Society (DMYKG) and the Paul‐Ehrlich‐Society for Chemotherapy (PEG)	12
Improved effectiveness of an increased dose of griseofulvin for treating Tinea capitis among refugee children in Israel: A retrospective cohort study	12
Prevalence of chronic pulmonary aspergillosis regarding time of tuberculosis diagnosis in Brazil	12
Exploring the clinical features and risk factors for children tinea capitis complicated with allergic diseases	11
Patients with recurrent vulvovaginal candidiasis exhibit a decrease in both the fungicidal activity of neutrophils and the proliferation of peripheral blood mononuclear cells	11
T‐cell dysfunction as a potential contributing factor in post‐COVID‐19 mucormycosis	11
Changing demographics and risk factors for cryptococcosis: A 12‐year review at a tertiary care centre	11
A review of significance of Aspergillus detection in airways of ICU COVID‐19 patients	11
Pneumocystis jirovecii pneumonia in patients with previously untreated acute myeloid leukaemia	10
Performance of the IMMY® sona Aspergillus lateral flow assay for the detection of galactomannan in tracheal aspirate samples from Brazilian patients with COVID‐19‐associat	10
Increased incidence of rhino‐orbital mucormycosis in an educational therapeutic hospital during the COVID‐19 pandemic in western Iran: An observational study	10
Responses of keratinocytes to Trichophyton mentagrophyte infection based on whole transcriptome analysis	10
The influence of CYP2C19 polymorphisms on voriconazole trough concentrations: Systematic review and meta‐analysis	10
Emergence of Candida auris in intensive care units in Algeria	10
Report of terbinafine resistantTrichophytonspp. in Italy: Clinical presentations, molecular identification, antifungal susceptibility testing and mutations in the squalene epoxidase gene	10
Disease burden and demographic characteristics of mucormycosis: A nationwide population‐based study in Taiwan, 2006–2017	10
Global epidemiological burden of fungal infections in cirrhosis patients: A systematic review with meta‐analysis	10
Saksenaea vasiformis infection: Extensive abdominal wall necrotizing fasciitis with systematic review and analysis of 65 cases	10
Global Insights and Trends in Research on Dermatophytes and Dermatophytosis: A Bibliometric Analysis	10
Multicenter Candida auris outbreak caused by azole‐susceptible clade IV in Pernambuco, Brazil	10
Issue Information	10
Paediatric cutaneous mucormycosis: A case report and review of the literature	9
Antifungal activity of aminopyrrolnitrin against Trichophyton verrucosum in a guinea pig model of dermatophytosis	9
Diagnostic values of ten  methods in patients with onychomycosis: A network meta‐analysis	9
The sphingolipid inhibitor myriocin increases Candida auris susceptibility to amphotericin B	9
Mucormycosis in Africa: Epidemiology, diagnosis and treatment outcomes	9
Epidemiology of dermatomycoses and onychomycoses in Ireland (2001–2020): A single‐institution review	9
As the virus sowed, the fungus reaped! A comparative analysis of the clinico‐epidemiological characteristics of rhino‐orbital mucormycosis before and during COVID‐19 pandemic	9
Update of the Epidemiology of the Sporotrichosis Epidemic in the state of Rio Grande do Sul, Brazil	9
Eumycetoma causative agents are inhibited in vitro by luliconazole, lanoconazole and ravuconazole	9
Issue Information	9
‘CT and CT image‐based texture image analysis in radiological diagnostics of allergic fungal rhinosinusitis’	9
Mechanism of azole resistance in Candida vulturna, an emerging multidrug resistant pathogen related with Candida haeumulonii and Candida auris	9
Surgical management of chronic pulmonary aspergillosis in Africa: A systematic review of 891 cases	9
Candida Infective Endocarditis in Patients With Candida spp. Bloodstream Infection: Risk Factors and 1‐ Year Mortality	8
Issue Information	8
In vitro activities of 8 antifungal agents against geophilic dermatophyte isolates	8
Combination therapy with itraconazole and terbinafine for phaeohyphomycosis caused by Exophiala spinifera: A case report and literature review	8
Author Index	8
Clinicopathological Analysis of Oral Paracoccidioidomycosis in Women	8
Abstracts	8
Effect of coccidioidomycosis prophylaxis in selecting non‐Candida albicans species amongst solid organ transplant recipients in Arizona	8
	8
Issue Information	8
Acitretin: Could it be a new therapeutic player in the field of onychomycosis?	8
Author Index	8
Rhinosporidiosis—Factors predicting disease recurrence	8
Issue Information	8
	8
Temporal trends in antifungal susceptibility of Cryptococcus neoformans isolates from a reference laboratory in the United States, 2011–2021	8
Invasive aspergillosis due to Aspergillus cryptic species: A prospective multicentre study	7
Differential lipase virulence in Malassezia furfur dimorphism isolated from pityriasis versicolor patients and healthy individuals	7
The role of oxidative stress in onychomycosis: Thiol/disulphide homeostasis	7
Concomitant use of isavuconazole and CYP3A4/5 inducers: Where pharmacogenetics meets pharmacokinetics	7
	7
Exploring the intersection of Aspergillus fumigatus biofilms, infections, immune response and antifungal resistance	7
Invasive aspergillosis in solid organ transplantation: Diagnostic challenges and differences in outcome in a Spanish national cohort (Diaspersot study)	7
	7
Effects of oestrogen on vulvovaginal candidosis	7
Majocchi's granuloma: Autoinoculation and adaption of Trichophyton rubrum with molecular evidence	7
	7
Issue Information	7
Issue Information	7
The clinical significance of Aspergillus‐positive respiratory samples	7
Cover Image	7
Effect of the implementation of clinical guidelines on management of candidemia in elderly patients	7
Issue Information	7
Green natural nail polish modified with essential oils to treat onychomycosis	7
Issue Information	7
Topical sertaconazole during pregnancy and risk of adverse pregnancy outcome and major congenital anomalies: Comparative study in the EFEMERIS database	7
Prognostic factors for mycological cure in patients with onychomycosis caused by Neoscytalidium dimidiatum: A retrospective cohort study	6
Efficacy of Amorolfine in Onychomycosis Treatment: A Mixed‐Effects Models and Multivariate Logistic Regression Analysis	6
Drug repurposing against Candida auris: A systematic review	6

Optimization of a commercial Histoplasma galactomannan EIA test in a population from an endemic area of histoplasmosis in southern Brazil	6
Epidemiology of dermatomycoses in children in Northern Mato Grosso 2015‐2020	6
Prototype early diagnostic model for invasive pulmonary aspergillosis based on deep learning and big data training	6
Characterisation of the nail microbiome in psoriatic and nonpsoriatic patients with onychomycosis	6
Cover Image	6
Analysis of 15 cases from a monocentric cohort of 307 liver abscesses	6
Machine‐learning‐based virtual screening to repurpose drugs for treatment of Candida albicans infection	6
Species distribution, azole resistance and related molecular mechanisms in invasive Candida parapsilosis complex isolates: Increase in fluconazole resistance in 21 years	6
Time and cost‐efficient identification of Trichophyton indotineae	6
Diagnosis of fungal opportunistic infections in people living with HIV from Guatemala and El Salvador	6
Voriconazole is superior to combined itraconazole/isotretinoin therapy and itraconazole monotherapy in recalcitrant dermatophytosis	6
Issue Information	6
Serious fungal disease incidence and prevalence in Indonesia	6
Tinea faciei clinical characteristics, causative agents, treatments and outcomes; a retrospective study in Thailand	6
Baseline chest computed tomography for diagnosis of invasive aspergillosis in patients with acute myeloid leukaemia treated with intensive chemotherapy: A retrospective single‐centre cohort study	6
Pan‐azole‐resistant Meyerozyma guilliermondii clonal isolates harbouring a double F126L and L505F mutation in Erg11	6
The prognostic factors for cryptococcal meningitis in non‐human immunodeficiency virus patients: An observational study using nationwide database	6
Comparison of dermoscopic characteristics on toenail onychomycosis in psoriatic and non‐psoriatic patients: A prospective study	6
Antifungal use via outpatient parenteral antimicrobial therapy	6
Implementation of rapid diagnostics assays for detection of histoplasmosis and cryptococcosis in central american people living with HIV	6
Children onychomycosis, a neglected dermatophytosis: A retrospective study of epidemiology and treatment	6
A survey of 701 cases of tinea faciei in Hangzhou, southeastern China, from 2018 to 2023	6
Incidence of Saccharomyces cerevisiae fungemia in hospitalised patients administered Saccharomyces boulardii probiotic	6